Uninfected HFFs, ARPE-19, and SHSY-5Y were treated with the indicated concentrations of Cl-A (A) and BB-Cl (B) for 24 h, and the number of viable cells was determined for each concentration using the MTT assay. Values are expressed as means ± SEM of three independent experiments. SH-SY5Y (C) and ARPE-19 (D) were infected with HSV-1 (MOI 1 PFU/cell) and then treated with increasing concentrations of Cl-A, which were given 1 h prior to virus adsorption and kept throughout the whole experiment. At 24 hpi, viral plaques were microscopically counted, and the number of plaques was plotted as a function of inhibitor concentration. Values are expressed as means ± SEM (error bars) of three independent experiments, *P P P (E) Protein lysates from uni...
(A). Single-step (high MOI) growth curve of WT and mutant HSV-1. Monolayers of Vero and HaCaT cells ...
<p>(A) Kinetics of p19 viral protein secretion in the supernatant of hCMEC/D3 and irradiated HTLV-1 ...
HFFs were infected with HSV-1 (MOI 1) and then treated with increasing concentrations of HF4 (A) or ...
(A-B) HFFs were infected with HSV-1 (MOI 1 PFU/cell) and then treated with increasing concentrations...
(A) Protein lysates from HFFs infected with HSV-1 (MOI 1 PFU/cell) at different hours post-infection...
<p>Vero cells were infected with HSV1 SC16 at an MOI of 1 for 16 hours. Cells were treated with 0 µM...
<p>HeLa cells were infected with HSV-1 KOS at MOI of 1. A) Infected cells were either untreated (no ...
(A-B) Volcano plot depicting the host (A, red dots) and viral (B, blue dots) citrullinated proteins ...
<p>(A) Titration of infectious virus production by plaque assay. Vero cells in triplicate were treat...
<p>A. Vero cells were seeded in a 24-well plate and infected with increasing concentrations (MOI fro...
<p>(A) HaCaT cells were infected with HSV-1 pretreated with MβCD (10 mM) for 30 min at room temperat...
<p>Confluent HEL cell cultures were exposed to 100 TCID<sub>50</sub> of clinical virus isolates [wil...
<p><b>(A)</b> Virus replication assays were performed in PTP1B+ and PTP1B<sup>-/-</sup> MEFs infecte...
<p>HEp-2 cells were inoculated with RSV <i>wt</i> strain A2 at an MOI = 1.0 and incubated for 24 hou...
<p>Individual sera were evaluated for HSV neutralizing antibody titer in a colorimetric assay employ...
(A). Single-step (high MOI) growth curve of WT and mutant HSV-1. Monolayers of Vero and HaCaT cells ...
<p>(A) Kinetics of p19 viral protein secretion in the supernatant of hCMEC/D3 and irradiated HTLV-1 ...
HFFs were infected with HSV-1 (MOI 1) and then treated with increasing concentrations of HF4 (A) or ...
(A-B) HFFs were infected with HSV-1 (MOI 1 PFU/cell) and then treated with increasing concentrations...
(A) Protein lysates from HFFs infected with HSV-1 (MOI 1 PFU/cell) at different hours post-infection...
<p>Vero cells were infected with HSV1 SC16 at an MOI of 1 for 16 hours. Cells were treated with 0 µM...
<p>HeLa cells were infected with HSV-1 KOS at MOI of 1. A) Infected cells were either untreated (no ...
(A-B) Volcano plot depicting the host (A, red dots) and viral (B, blue dots) citrullinated proteins ...
<p>(A) Titration of infectious virus production by plaque assay. Vero cells in triplicate were treat...
<p>A. Vero cells were seeded in a 24-well plate and infected with increasing concentrations (MOI fro...
<p>(A) HaCaT cells were infected with HSV-1 pretreated with MβCD (10 mM) for 30 min at room temperat...
<p>Confluent HEL cell cultures were exposed to 100 TCID<sub>50</sub> of clinical virus isolates [wil...
<p><b>(A)</b> Virus replication assays were performed in PTP1B+ and PTP1B<sup>-/-</sup> MEFs infecte...
<p>HEp-2 cells were inoculated with RSV <i>wt</i> strain A2 at an MOI = 1.0 and incubated for 24 hou...
<p>Individual sera were evaluated for HSV neutralizing antibody titer in a colorimetric assay employ...
(A). Single-step (high MOI) growth curve of WT and mutant HSV-1. Monolayers of Vero and HaCaT cells ...
<p>(A) Kinetics of p19 viral protein secretion in the supernatant of hCMEC/D3 and irradiated HTLV-1 ...
HFFs were infected with HSV-1 (MOI 1) and then treated with increasing concentrations of HF4 (A) or ...